Combinations ; See Below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Viracept | Roche | Roche Products | 250mg | 270 | Tablet | per tablet | KES 14,756.00 |
| Viracept | Roche | Roche Products | 50mg | 144g | Powder | KES 4,453.00 |
| Nelfinavir More info | |
|---|---|
| Mode Of Action | Protease inhibitors (PI) Inhibits HIV proteases, preventing viral maturation and replication |
| Drug Indication | HIV infection |
| Precautions | Monitoring of cholesterol and triglycerides; drug blood concentration decreases in pregnancy, hence a need for monitoring plasma concentration with intent of adjusting the dose accordingly. |
| Contra-Indications | Amiodarone; quinidine. |
| Side Effects | Most common: diarrhoea. Others: abdominal pains; flatulence; rash; hypersensitivity; fatigue; hepatitis; pacreatitis; oral ulcers and nephrolithiasis. |
| Dosage | 750mg TID or 1250mg BD. Children 2-13 yrs: 25-30mg/kg TID (max. 750mg). (Taken with meals for best absorption) |
| Pregnancy Category | Category B2 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals are inadequate or lacking but available data show no evi-dence of an increased occurrence of foetal damage. Studies in animals are inadequate or lacking but available data show no evi-dence of an increased occurrence of foetal damage. |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Hiv Chemotherapy |